New MS pill shows promise in early trial
NCT ID NCT06083753
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 26 times
Summary
This study tested an oral medication called PIPE-307 in 182 adults with relapsing-remitting multiple sclerosis (MS). Participants took either a low dose, a high dose, or a placebo pill for about 30 weeks. The main goals were to check for side effects and measure changes in vision. Researchers also looked at walking speed and hand function. The study is complete, and results will help decide if larger trials are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alta Bates Summit Medical Center
Berkeley, California, 94705, United States
-
Aqualane Clinical Research
Naples, Florida, 34105, United States
-
Arizona Neuroscience Research, LLC
Phoenix, Arizona, 85032, United States
-
Bhupesh Dihenia, MD, PA
Lubbock, Texas, 79410, United States
-
Clinical Trial Network
Houston, Texas, 77074, United States
-
Colorado Springs Neurological Associates
Colorado Springs, Colorado, 80907, United States
-
Dent Neurologic Institute
Amherst, New York, 14226, United States
-
MS and Neuromuscular Center of Excellence
Clearwater, Florida, 33761, United States
-
Multicare Neuroscience Center of Washington
Tacoma, Washington, 98405, United States
-
Neurological Associates of Long Island, P.C.
Lake Success, New York, 11042, United States
-
Neurology Center of New England P.C.
Foxborough, Massachusetts, 02035, United States
-
Oklahoma Research Foundation - MS Center of Excellence
Oklahoma City, Oklahoma, 73104, United States
-
Shepherd Center
Atlanta, Georgia, 30309, United States
-
Sibyl Wray Neurology PC
Knoxville, Tennessee, 37922, United States
-
UW Medicine MS Center
Seattle, Washington, 98133, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of New Mexico/Health Science Center/MIND Imaging Center/MS Specialty Clinic
Albuquerque, New Mexico, 87106, United States
-
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Xenosciences
Phoenix, Arizona, 85004, United States
Conditions
Explore the condition pages connected to this study.